Flucelvax (TIVc or QIVc) Pregnancy Registry

CompletedOBSERVATIONAL
Enrollment

692

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Influenza, HumanPregnancyBirth Defect
Interventions
BIOLOGICAL

Flucelvax Trivalent Influenza Vaccine

"Flucelvax is a cell culture seasonal trivalent influenza vaccine that contains the following influenza hemagglutinin antigens: 1) A/H1N1-like virus, 2) A/(H3N2)-like virus, 3) B/Yamagata lineage or B/Victoria lineage~Vaccine exposure in routine care (no vaccination per protocol)"

BIOLOGICAL

Flucelvax Quadrivalent Influenza Vaccine

"Flucelvax Quadrivalent is a cell culture seasonal quadrivalent influenza vaccine that contains the following influenza hemagglutinin antigens: 1) A/H1N1-like virus, 2) A/(H3N2)-like virus, 3) B/Yamagata lineage, 4) B/Victoria lineage~Vaccine exposure in routine care (no vaccination per protocol)"

Trial Locations (1)

28405

Syneos Health, Wilmington

All Listed Sponsors
lead

Seqirus

INDUSTRY

NCT03438487 - Flucelvax (TIVc or QIVc) Pregnancy Registry | Biotech Hunter | Biotech Hunter